Histological characteristics of pulmonary Langerhans cell histiocytosis

Zdravko Kosjerina Orcid logo ,
Zdravko Kosjerina
Vesna Kosjerina-Oštrić
Vesna Kosjerina-Oštrić

Published: 01.12.2012.

Biochemistry

Volume 29, Issue 3 (2013)

pp. 917-923;

https://doi.org/10.5937/matmed1303917k

Abstract

LCH is characterized by the presence of Langerhans cells juxtaposed against a backdrop of hematopoietic cells, including T-cells, macrophages, and eosinophils. The investigated material included open lung biopsy samples taken from seven patients (four males and three females) at the mean age of 23.2 years. They were all smokers. The intensity of the histological lesions was semiquantitatively measured, differentiating three intensity grades: mild, moderate and intense. In most cases (3/7), the interalveolar septa were focally and intensively thickened. The inÀ ammatory in¿ ltrates in the septa were focal, intense in 3/7, moderate in 1/7, and mild in 1/7 specimens. Lymphocytes prevailed, followed by macrophages, eosinophil granulocytes, and plasma cells. The lumen of the alveoli was occupied by a few macrophages and lymphocytes, sparse plasma cells and few eosinophil granulocytes. The alveolar cells were focally cuboid in 7 cases. Histiocyte aggregates were detected in all specimens, most frequently localized peribronchiolarly (7/7) and in the intraalveolar septa (4/7). The aggregates had either a clear (15/25), or a relatively clear (10/25) demarcation line against the periphery. The aggregates were predominantly composed of Langerhans’ cells (7/7, abundant), followed by eosinophil granulocytes (abundant in 4/25, moderate in 8/25, sparse in 13/25), lymphocytes (sparse in 10/25 and moderate in 15/25 cases), and plasma cells (sparse in 10/25). The Langerhans’ cells were CD1a and S 100 positive. Histiocyte aggregates were registered in all biopsy samples; the Langerhans’ cells were CD1a and S100 positive.

Keywords

References

1.
Caminati A, Harari S. Smoking-related Interstitial Pneumonias and Pulmonary Langerhans Cell Histiocytosis. Proc Am Thorac Soc. 2006;299–306.
2.
Moore A, Godwin J, Muller N. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology. 1989;249–54.
3.
Sundar K, Gosselin M, Chung H, Cahill B. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest. 2003;1673–83.
4.
Colby T, Lombard C. Histiocytosis X in the lung. Hum Pathol. 1983;847–56.
5.
Delobbe A, Durieu J, Duhamel A. Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Eur Respir J. 1996;2002–6.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners